PLEASANTON, Calif. -- Thoratec Corporation, a world leader in device-based mechanical circulatory support therapies to save, support and restore failing hearts, said today it has acquired the ...

Abbott Laboratories (ABT 0.81%) announced on Tuesday its in-development implantable heart pump system received the Breakthrough Device designation from the U.S. Food and Drug Administration (FDA). The ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. The FDA has designated Medtronic’s recall of two parts ...

An “Urgent Medical Device Correction” issued by Abbott-Thoratec for its HeartMate II LVAS Pocket System Controller has been classified by the US Food and Drug Administration (FDA) as a class I recall, ...

Abbott Laboratories continues to extend its list of milestones in the cardiovascular space. The Abbott Park, IL-based company has now won Breakthrough Device Designation from FDA for the ...

This coordinated effort will standardize emergency care practices for VAD patients across all UAB sites of care, including UAB Hospital, UAB St. Vincent’s East, UAB St. Vincent’s Birmingham, UAB St.

Ventricular assist devices are mechanical pumps that take over the function of the damaged ventricle in order to re-establish normal hemodynamics and end-organ blood flow. In addition, VADs unload the ...

Enrolment for the US-based trial is scheduled to start in mid-2026, with initial results expected in the fourth quarter.

Mechanical circulatory support systems for the treatment of end-stage heart failure are now available for a wide variety of clinical situations and support times. Extracorporeal membrane oxygenation ...

During embryonic development, the right ventricle is formed from the secondary heart field into a crescent-shaped, thin-walled structure. 6 It is the most anterior heart chamber, sitting just beneath ...